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Abstract
Magnetic separation technology, using magnetic particles, is quick and easy method for sensitive and
reliable capture of specific proteins, genetic material and other biomolecules. The technique offers
an advantage in terms of subjecting the analyte to very little mechanical stress compared to other
methods. Secondly, these methods are non-laborious, cheap and often highly scalable. Moreover,
techniques employing magnetism are more amenable to automation and miniaturization. Now that
the human genome is sequenced and about 30,000 genes are annotated, the next step is to identify
the function of these individual genes, carrying out genotyping studies for allelic variation and SNP
analysis, ultimately leading to identification of novel drug targets. In this post-genomic era,
technologies based on magnetic separation are becoming an integral part of todays biology
laboratory. This article briefly reviews the selected applications of magnetic separation techniques
in the field of biotechnology, biomedicine and drug discovery.
Introduction
Magnetic fluids or ferrofluids as they are often called
mainly consist of nano sized iron oxide particles (Fe3O4 or
γ-Fe2O3) which are suspended in carrier liquid. In recent
years, substantial progress has been made in developing
technologies in the field of magnetic microspheres, mag-
netic nanospheres and ferrofluids. Techniques based on
using magnetisable solid-phase supports (MSPS) have
found application in numerous biological fields viz. diag-
nostics, drug targeting, molecular biology, cell isolation
and purification, radio immuno assay, hyperthermia
causing agents for cancer therapy, nucleic acid purifica-
tion etc [1–3]. Although often referred to as magnetic,
many of the particles currently used are superparamag-
netic, meaning that these particles can be easily magnet-
ized with an external magnetic field and redispersed
immediately once the magnet is removed. Currently avail-
able formats of particles can be broadly classified into
unmodified or naked particles, chemically derivatized
particles with general specificity ligands (streptavidin,
Protein A etc) and chemically derivatized particles with
specific recognition groups viz. monoclonal and polyclo-
nal antibodies [4]. This article discusses the selected
advancement made in the field of biotechnology, medi-
cine and drug discovery using magnetically driven separa-
tion techniques.
Drug discovery and genomics applications
The modern drug discovery process emphasizes rapid data
generation and analysis to identify promising new chem-
ical entities as well as new drug targets early in the devel-
opment cycle. At every step of the rapidly evolving drug
discovery process, dozens of technologies and products
are required. But innovations in newer technologies for
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genomics and proteomics are changing the face of drug
discovery. Automation has become essential in allowing
researchers to meet the high through demands of today's
research environment. The main thrust area where mag-
netic separation is applied in drug discovery is sample
preparation that includes high throughput genome isolation
for sequencing or PCR amplification to carry out genotyp-
ing, SNP scoring or expression profiling. The inherent
benefits offered by magnetic handling includes, reduced
reagent costs, elimination of labour intensive steps, easy
automation and yield of high purity DNA in less amount
of time compared to conventional methods.
Highthroughput DNA isolation
Isolation of DNA is a prerequisite step for many molecular
biology techniques. The separation of DNA from the com-
plex mixtures in which they are often found is frequently
necessary before other studies and procedure like
sequencing, amplification, hybridization, detection etc.
The presence of large amounts of cellular or other contam-
inating material like proteins and RNA, in such complex
mixtures often impedes many of the reactions and tech-
niques used in molecular biology [5]. The conventional
protocol for extracting DNA involves cell lysis followed by
removal of contaminating cellular components such as
proteins, lipids and carbohydrates; and finally isolating
DNA using a series of precipitation and centrifugation
steps, which are difficult to automate. Improvement in
methods for isolating DNA has been made and more
recently, methods that rely on the use of solid phase have
been proposed. Adsorbents that provide fast, efficient
DNA purification are important for making this proce-
dure amenable to automation. The discovery in late 80's
that silica can be used as adsorbent for DNA isolation [6],
became the basis for most of the DNA isolation kits cur-
rently available. One of these kits involves isolation of
DNA using silica coated magnetic particles [7].
A high throughput genome isolation protocol has been
developed, which is based on SPRI (Solid Phase Reversi-
ble Immobilization) chemistry [8,9]. The SPRI protocol is
based on DNA binding to the surface of carboxyl coated
paramagnetic particles under the condition of high salt
and PEG. The procedure has been developed and opti-
mized for single stranded DNA isolation, such as M13
phage and double stranded plasmid DNA utilizing car-
boxyl coated magnetic particles. The SPRI protocol has
allowed the development of an automated procedure in a
microplate format with a throughput of about 200, 000
DNA preparations per day, thus becoming a fastest micro-
plate plate based DNA purification system in use on the
human genome sequencing.
Magnetic separation of poly (A) mRNA
A number of methods have been reported for isolation of
total RNA from a variety of cells or tissues. Chirgwin et al.
[10] developed a method for efficient isolation of total
RNA by homogenization in a 4 M solution of guanidium
thiocyanate containing 0.1 M 2-mercaptoethanol.
Homogenization is followed by extraction of RNA by eth-
anol or by ultracentrifugation through cesium chloride.
This method was further modified by Chomczynski and
Sacchi [11] to devise a rapid single step isolation proce-
dure for RNA. It involves extraction of RNA using a mix-
ture of guanidium thiocyanate and phenol-chloroform.
Many RNA isolation kits are available based on the above
two protocols. All these methods isolate RNA on the basis
of its biochemical properties. In contrast, biomagnetic
separation of mRNA is based on specific complementary
hybridization between poly A sequence of isolated mRNA
and oligo (dT)25 sequence covalently linked to the surface
of paramagnetic particles. In this method oligo (dT)25
coated magnetic beads are added to crude cell or tissue
lysate. During incubation poly (A) mRNA from the lysate
are caught onto the surface of oligo (dT)25 coated mag-
netic beads. The beads/mRNA complex is then washed
magnetically. The mRNA thus isolated is either eluted or
directly applied for many downstream applications which
includes cDNA library construction, Substractive hybridi-
zation, Northern hybridization, RT-PCR and in vitro trans-
lation [12].
Isolation of nucleic acid binding biomolecules
The isolation of specific molecules based on its interac-
tion with complementary binding partner is emerging as
important technologies in many field of research. The iso-
lation and characterization of specific transcripts or pro-
teins can be employed to monitor the progression of
disease. Several kits are available in the market that works
on the principle of magnetic labeling and direct isolation
of biotinylated molecules such as DNA, RNA or proteins
onto streptavidin coated magnetic beads (µMACS strepta-
vidin Microbeads from Miltenyi Biotec, Germany). These
biotinylated molecules can then be used for indirect isola-
tion of non-biotinylated target molecules that may inter-
act with them [13]. The procedure involves complex
formation between the biotinylated probe (DNA, RNA or
proteins) and the target molecule (i.e. interacting biomol-
ecules DNA, RNA or protein). Based on the interaction of
biotin-streptavidin, the probe-target complex is then sep-
arated from rest of the component by addition of strepta-
vidin coated magnetic beads. The complex is magnetically
isolated and washed to remove non-specifically bound
molecules. The non-biotinylated target molecules can be
either eluted off from the complex with high purity,
whereas the magnetically labeled biotinylated probe
remains bound to the column (Fig. 1). This technique has
potential for rapid and efficient screening ofBioMagnetic Research and Technology 2003, 1 http://www.biomagres.com/content/1/1/2
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Isolation of nucleic acid binding molecules Figure 1
Isolation of nucleic acid binding molecules. Biotinylated DNA is added to the cell lysate or a protein mixture that con-
tains protein which interacts with the DNA (i). Streptavidin magnetic beads are added that binds to the complex (biotin-DNA-
protein) based on its affinity for biotin (ii). The complex is separated magnetically from the mixture (iii). Reprinted, with per-
mission, from materials provided by Miltenyi Biotec, GmbH, Germany.
(i)
(ii)
(iii)BioMagnetic Research and Technology 2003, 1 http://www.biomagres.com/content/1/1/2
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transcriptional and translational regulatory proteins.
Alam and co-workers have also used target DNA-conju-
gated magnetic beads for rapid screening of DNA-binding
peptide ligands from solid phase combinatorial library
[14].
Proteomics Applications
Magnetocapture protein interaction assays
Magnetic particles are now increasingly used as carriers for
binding proteins, enzymes and drugs. Studies have shown
that proteins and enzymes can be bound covalently to
naked magnetic particles in the presence of carbodiimide
[15]. Such immobilization procedures for proteins,
enzymes or drugs will have a major impact in various
areas of medicine and biotechnology. The immobilized
biomolecules can be used directly for a bioassay or as
affinity ligands to capture or modify target molecules or
cells. On this basis, Ni-NTA (nitriloacetic acid) tagged
magnetic agarose beads have been used for versatile mag-
netocapture assays using 6xHis-tagged proteins [16]. The
procedure involves use of metal chelating nitriloacetic
acid (NTA) groups covalently bound to the surface of aga-
rose beads, which contain strong magnetic particles. The
beads are precharged with nickel, which is ready to cap-
ture 6xHis-tagged proteins for sensitive interaction assays
or microscale purification of 6xHis tagged proteins (Fig.
2). Thus, this technique bridge the gap between purifica-
tion-scale procedures using Ni-NTA metal chelate affinity
chromatography resins and microplate-based assays [17].
Magnetocapture protein interaction assays Figure 2
Magnetocapture protein interaction assays. Ni-NTA magnetic agarose beads precharged with nickel captures 6xHis-
tagged proteins, which can be used for studying protein-protein (i) and DNA-protein interactions (ii), and immunoassay proce-
dures using antibodies specific for antigens present on the captured 6xHis-tagged biomolecule or antigens present on interac-
tion partners bound to the captured 6xHis-tagged biomolecule (iii). Reprinted, with permission, from materials provided by 
Qiagen, GmbH, Germany.
(i) (iii) (ii)BioMagnetic Research and Technology 2003, 1 http://www.biomagres.com/content/1/1/2
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Other procedures for magnetic affinity separations of var-
ious proteins have been summarized recently [18].
Biomedical Applications
Drug Targeting Using Magnetic Targeted Carriers
Magnetically guided drug targeting has been attempted in
order to increase the efficacy and reduce the unpleasant
side effects associated with chemotherapy. This method of
drug delivery involves immobilization of drug or radionu-
clide in biocompatible magnetic nano- or microspheres
[19]. This method of delivery makes chemotherapy more
effective by increasing the drug concentration at the
tumour site, while limiting the systemic drug concentra-
tion. FeRx Inc. of San Diego have designed Magnetic Tar-
geted Carriers termed MTCs for site-specific targeting,
tissue retention, and sustained release of drugs. These
MTCs are composed of elemental iron particles and acti-
vated carbon. MTCs (1–2 µm in size) can adsorb and des-
orb pharmaceutical agents such as doxorubicin (DOX).
Vialed MTCs are mixed with an anticancer drug already in
solution; the mixture is then introduced into the catheter.
The drug delivery using MTCs includes insertion of cathe-
ter into an arterial feed to the tumor, followed by applica-
tion of powerful magnetic field to cause the MTC-DOX to
extravasate through the capillary bed into the targeted tis-
sue (Fig. 3). The field is left in place for another 15 min-
utes; after removal of the magnet, the particles remain
trapped in the tumor, where the drug is then released [20].
FeRx has already initiated phase III clinical trial for MTC-
DOX formulation [21]. Like wise, Hafeli and co-workers
have carried out preclinical studies in collaboration with
FeRx for treatment of liver and brain tumors using MTCs
labeled with β-emitters such as Rhenium-188 and
Yttrium-90 [22]. Although the main research concern of
MTC-drug therapy is cancer treatment, the technology is
not limited to this, other drugs that are deliverable in this
manner include antibiotics, thrombolytics, anti-inflam-
matories, peptides and steroids.
Magnetoliposomes as drug delivery vehicles
Magnetoliposomes are magnetic derivatives of liposomes
and can be prepared by entrapment of ferrofluids within
the core of liposomes [23]. Several groups have investi-
gated the uses of magnetoliposomes for site specific tar-
geting [24], cell-sorting [25] and as magnetic resonance
contrast enhancing agents [26].
Babincova et al. [27] have tried to use magnetoliposomes
with encapsulated doxorubicin (DOX) for site specific
chemotherapy in response to externally applied AC mag-
netic field. The result of this study showed that magnetol-
iposomes can be specifically heated to 42°C in a few
minutes and during this, the encapsulated doxorubicin is
massively released. Another in vivo studies for site specific
targeting using magnetoliposomes incorporated with
adriamycin (ADR), showed that administration of mag-
netic ADR liposomes under an applied external magnetic
force produced approximately 4-fold higher maximum
ADR concentration in the tumor than did administration
of ADR solution alone. These results suggested that sys-
temic chemotherapy could effectively control the primary
tumor without significant side effects, due to the targeting
of magnetic ADR liposomes [28,29].
Magnetotactic bacteria belonging mainly to Magnetospiril-
lum  species produces ferromagnetic crystalline particles
consisting of magnetite (Fe3O4) or greigite (Fe3S4). These
are called bacterial magnetic particles (BMPs). The BMPs
are small in size (50–100 nm) and disperse very well
because they are covered with a stable lipid membrane
[30]. Magnetoliposomes containing cis-diamminedichlo-
roplatinum (II) (CDDP) prepared using BMPs have also
been evaluated for targeting and controlled release of
drugs at tumor site. It has been observed from such studies
that the capture volume of the magnetoliposomes with
BMPs was 1.7 times higher than the ones with artificial
magnetic particles. Also, when a rotating magnetic field
was applied to these magnetoliposomes, the contents of
them were released over 2 hours, suggesting that magne-
toliposomes containing CDDP shows antitumor activity
and that the controlled release of drugs from magnetoli-
posomes is possible [31].
Drug targeting using MTCs Figure 3
Drug targeting using MTCs. MTCs are composite of ele-
mental iron and activated carbon with anticancer drug 
adsorbed onto it. MTCs are delivered intra-arterially via a 
catheter to the desired site by externally applied magnetic 
field. The magnetic field aids in particle localization and reten-
tion at targeted site by extravasation of the particles into the 
surrounding tissue. Reprinted, with permission, from materi-
als provided by FeRx Inc., San Diego, CA.
Magnetic Field
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Magnetic fluid hyperthermia
Magnetic fluids have been investigated as potential hyper-
thermia causing agents due to their high specific absorp-
tion rate (SAR). Hyperthermia is a promising approach for
cancer treatment that uses AC magnetic fields to heat tar-
get areas (cancer tissue) containing magnetic fluids. To
study the biological effects of AC magnetic field excited
ferrofluids, both in-vitro and in-vivo studies have been car-
ried out in cancer cell lines and spontaneously induced
tumors in animal models. The results of these studies have
shown that magnetic fluid hyperthermia is able to reduce
the viability of cancer cells, thereby indicating the poten-
tial of this therapy [32]. There also exist the possibility of
combination therapy, which would include hyperthermia
treatment followed by chemotherapy or gene therapy. The
approach involves use of magnetic nano- or microspheres
or magnetoliposomes containing a drug to cause hyper-
thermia using the standard procedure, followed by the
release of encapsulated drug that will act on the injured
cells. It is anticipated that the combined treatment might
be very efficient for treating solid tumor [19].
Cell Sorting Applications
Immunomagnetic cell isolation and separation
Immunomagnetic cell separation methods have become
increasingly popular among the cell biologist. The general
approach involves use of paramagnetic particles coated
with antibodies against the target specific cell surface mol-
ecules. The method employs two schemes for isolating the
target cell, direct method that involves coupling of affinity
ligand (antibody) onto the magnetic particles, which are
then directly added to the sample containing the target
cells. During the incubation the magnetic particles binds
the target cells that can then be recovered using a magnet.
While in case of indirect method, a free affinity ligand (an
appropriate antibody) is first added to the cell suspension.
After incubation excess unbound affinity ligand is
removed by washing, and the antibody-target cell com-
plex is then captured by magnetic particles bearing an
affinity ligand (secondary antibody) with the affinity for
the primary label. Both positive and negative selection can
be performed with immunomagnetic separation. In case
of positive selection target cellular subsets are magneti-
cally labeled and subsequently separated, while negative
selection involves target purification by removing all
other contaminating cells [33,34].
Using this technology large number of cell types has been
isolated to date. Some of the examples where
immunomagnetic separation technology has been
applied includes, detection and removal of circulating
tumor cells from peripheral blood [35], isolation of anti-
gen specific CD 8+ T cells [36], selective separation of
CD34+ cells [37], isolation and enrichment of retinal gan-
glion cells (RGCs) for culturing [38] etc. Immunomag-
netic separation is used extensively for detection of
pathogenic bacteria in clinical, food and environmental
samples [33,39]. In addition to whole cell isolation, even
cell organelles can be selectively separated using magnetic
particles. The lysosome fraction was isolated from the
amoeba Dictyostelium discoideum after feeding with dex-
tran-based nanoparticles and subsequent homogeniza-
tion [40]. Likewise a variety of cell types can be isolated
using automated systems and different surface coated
magnetic particles that are available from Miltenyi Biotec,
Germany, or StemCell Technologies, USA.
Immunomagnetic assays
Immunoassays are becoming an important tool in clinical
diagnostics and in fundamental investigations, because of
its sensitivity, specificity and general applicability. Mag-
netic particles have been applied increasingly for various
immunoassays that include fluoroimmunoassays,
enzyme immunoassays or radioimmunoassays. Magnetic
particles bound with primary or secondary antibodies are
used for separation and quantification of antigens. Use of
magnetically bound antibodies eliminates the centrifuga-
tion step thus reducing assay time and simplifying opera-
tion thereby increasing the efficiency and accuracy of the
assay. Matsunaga and co-workers [41] have developed a
novel fluoroimmunoassay method, where a fluorescein
isothiocyanate (FITC) conjugated monoclonal anti-
Escherichia coli antibody was immobilized onto bacterial
magnetic particles (BMPs) for detection and removal of E.
coli. The same group has also developed a chemilumines-
cence enzyme immunoassay with BMPs using IgG as a
model antigen [42]. Likewise a magnetic bead based
ELISA has been developed for detection of Staphylococcus
species [43].
Conclusion
Magnetic separation technologies have been applied in
diverse field of biology. This includes high throughput
isolation of nucleic acids, proteins, cells or cell organelles.
Now a days, several instruments are available from differ-
ent companies that couples separation of biomolecules
with its detection in terms of its quantification or its inter-
actions with other biomolecules. This instruments either
uses directly ferromagnetic particle as label (magneto
assay) or couples magnetic particles with other detection
methods such as fluorescence or chemiluminescence. It
might be possible in near future that magnetic particles
would be used as detection probes for a variety of assays,
replacing labeling techniques such as fluorescence, chemi-
luminescence and radioactivity. In our lab, research work
on similar lines is proposed. The work involves develop-
ing a detection method for bio-molecular interaction
using magnetic particles as label. The method that is
planned to be developed would have special emphasis in
microarray technology, where bio-molecular interactionsBioMagnetic Research and Technology 2003, 1 http://www.biomagres.com/content/1/1/2
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like cDNA-mRNA or DNA-DNA are the basis for deter-
mining gene expression or allelic variation. To conclude
what can be said is, magnetism based separation technol-
ogy holds immense potential in this post genomics era
because of its high speed, low cost and amenability of
automation.
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